Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4852354
Max Phase: Preclinical
Molecular Formula: C40H67N17O9
Molecular Weight: 930.09
Molecule Type: Unknown
Associated Items:
ID: ALA4852354
Max Phase: Preclinical
Molecular Formula: C40H67N17O9
Molecular Weight: 930.09
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCC(=O)NCC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C40H67N17O9/c1-21(2)18-29(37(66)54-26(8-5-17-50-40(46)47)35(64)56-28(32(41)61)19-22-9-11-23(58)12-10-22)57-36(65)27-13-14-30(59)51-20-31(60)52-24(6-3-15-48-38(42)43)33(62)53-25(34(63)55-27)7-4-16-49-39(44)45/h9-12,21,24-29,58H,3-8,13-20H2,1-2H3,(H2,41,61)(H,51,59)(H,52,60)(H,53,62)(H,54,66)(H,55,63)(H,56,64)(H,57,65)(H4,42,43,48)(H4,44,45,49)(H4,46,47,50)/t24-,25+,26+,27+,28+,29+/m1/s1
Standard InChI Key: QLVBPSCWUQIUTJ-JTXVVRDHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 930.09 | Molecular Weight (Monoisotopic): 929.5308 | AlogP: -4.93 | #Rotatable Bonds: 23 |
Polar Surface Area: 452.72 | Molecular Species: BASE | HBA: 12 | HBD: 18 |
#RO5 Violations: 3 | HBA (Lipinski): 26 | HBD (Lipinski): 22 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.47 | CX Basic pKa: 12.07 | CX LogP: -7.01 | CX LogD: -12.56 |
Aromatic Rings: 1 | Heavy Atoms: 66 | QED Weighted: 0.03 | Np Likeness Score: 0.40 |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):